Ignite Creation Date:
2024-05-06 @ 3:15 AM
Last Modification Date:
2024-10-26 @ 11:30 AM
Study NCT ID:
NCT02243111
Status:
TERMINATED
Last Update Posted:
2016-01-21
First Post:
2014-09-08
Brief Title:
Detecting Pulmonary Arterial Hypertension PAH in Patients With Systemic Sclerosis SSc by Ultrasound
Sponsor:
Echosense Ltd
Organization:
Echosense Ltd
Study Overview
Official Title:
Evaluation of Lung Doppler Signals LDS in Detecting Pulmonary Arterial Hypertension PAH in Patients With Systemic Sclerosis SSc
Status:
TERMINATED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Low recruitment rate
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Doppler signals can be recorded from the lung parenchyma by means of a pulsed Doppler ultrasound system incorporating a special signal processing package ie the transthoracic parametric Doppler TPD EchoSense Ltd Haifa Israel Systemic sclerosis patients often develop pulmonary vascular disease leading to pulmonary hypertension The TPD system may provide important insight into pulmonary blood vessels characteristics by the LDS signals that are related to pulmonary hypertension
The TPD performance in detecting PAH in SSc patients will be assessed in the study
The TPD performance in detecting PAH in SSc patients will be assessed in the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None